Aleix Fabregat

Grup de recerca

Biomarcadors i medicina de precisió de laboratori en hepatologia, metabolisme i malalties rares (HEMERA-Lab) Accredited researcher (R3A)

afabregat@clinic.cat 0000-0002-4855-0306

Segueix-lo/a a:

El perfil de ResearchGate de Aleix Borja .Aquest enllaç s'obre en una nova pestanya.
El perfil de Linkedin de Aleix Borja .Aquest enllaç s'obre en una nova pestanya.

Publicacions destacades

Overdiagnosed and oversupplemented: the iatrogenic rise of vitamin D toxicity

Autors:
Fabregat-Bolufer, Aleix B; Martin-Alonso, Carlos; Escola-Rodriguez, Alba; Morales-Ruiz, Manuel;

Referència: EUROPEAN JOURNAL OF ENDOCRINOLOGY 2026.
Can AI Outperform Human Aspirants? Evaluating 3 ChatGPT Models on the Spanish FIR and BIR Specialized Health Examinations

Autors:
Verdu, Gonzalo; Rayo, Alejandro Calvera; Fabregat-Bolufer, Aleix B;

Referència: Journal Of Applied Laboratory Medicine 2025.
Data-Driven Reference Intervals in Modern Laboratory Medicine: New Web Tools to Refine Vitamin D Status

Autors:
Barragan Munoz, Alex; Fabregat-Bolufer, Aleix B;

Referència: Journal Of Applied Laboratory Medicine 2025.
Comparison of two automated immunoassays for quantifying ProGRP, SCC and HE4 in serum: impact on diagnostic accuracy

Autors:
de Medrano, Jaime I Sainz; Laguna, Javier; Julian, Judit; Filella, Xavier; Fabregat, Aleix;

Luquin, Maria; Hurtado, Harol H; Humanes, Alba Garcia; Morales-Ruiz, Manuel; Fernandez-Galan, Esther.

Referència: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION 2025.
Redefining vitamin D status: Establishing population-based indirect reference intervals through big data analysis

Autors:
Fabregat-Bolufer, Aleix B; Escola-Rodriguez, Alba; Bedini-Chesa, Jose Luis; Casals, Gregori; Morales-Ruiz, Manuel;

Filella, Xavier.

Referència: CLINICA CHIMICA ACTA 2025.
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia

Autors:
Pineyroa, Juan A; Lopez-Oreja, Irene; Nadeu, Ferran; Martinez-Farran, Ares; Arostegui, Juan Ignacio;

(...)

Bea, Silvia; Campo, Elias; Delgado, Julio; Colomer, Dolors; Mozas, Pablo.

Referència: Cells 2024.
Diagnosis of cocaine-induced midline destructive lesions

Autors:
Escola-Rodriguez, Alba; Parra-Robert, Marina; Carrasco-Gomez, Daniel; Escartin-Diez, Teresa; Fabregat-Bolufer, Aleix B;

Referència: CLINICAL TOXICOLOGY 2023.
Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain) GONOvig project

Autors:
Aleix Borja Fabregat Bolufer; Felipe Bueno Ferrando; David Navarro Ortega; Javier Colomina Rodríguez;

Referència: 2023.
Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact

Autors:
Mozas, Pablo; Pineyroa, Juan A; Nadeu, Ferran; Magnano, Laura; Rivero, Andrea;

(...)

Arostegui, Juan Ignacio; Aymerich, Marta; Lopez-Guillermo, Armando; Campo, Elias; Delgado, Julio.

Referència: HAEMATOLOGICA 2021.
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma

Autors:
Mozas, Pablo; Rivero, Andrea; Rivas-Delgado, Alfredo; Fabregat, Aleix; Pineyroa, Juan A;

(...)

Campo, Elias; Arostegui, Juan I; Blade, Joan; Magnano, Laura; Lopez-Guillermo, Armando.

Referència: BRITISH JOURNAL OF HAEMATOLOGY 2021.

Projectes destacats

Treatment of metabolic liver disease using gold nanoenzymes with multicatalytic activity

Investigador/a principal: Gregori Casals Mercadal

Finançador: Instituto de Salud Carlos III (ISCIII)

Codi: PI24/00688

Durada: 01/01/2025 - 31/12/2027
Function and therapeutic potential of RNA helicases and miR-122a-5p in liver regeneration and cancer

Investigador/a principal: Manuel Morales Ruiz

Finançador: Agencia Estatal de Investigacion (AEI)

Codi: PID2022-138243OB-I00

Durada: 01/10/2024 - 31/03/2026
Proyecto GONOvig

Finançador: Hospital de la Ribera

Codi: PIBR17/04

Durada: 01/03/2017

Web: https://roderic.uv.es/items/7c1f2c1f-7d54-4e9d-b5d2-dfcdd26c92c3

Aleix Fabregat

Grup de recerca

Publicacions destacades

Projectes destacats

Treatment of metabolic liver disease using gold nanoenzymes with multicatalytic activity

Function and therapeutic potential of RNA helicases and miR-122a-5p in liver regeneration and cancer

Proyecto GONOvig

Subscriu-te a la Newsletter del Clínic